YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer
1 other identifier
interventional
N/A
7 countries
23
Brief Summary
The purpose of this study is to determine the optimal dosage of YM598 for slowing down disease progression in patients with rising PSA after initial therapy for localized prostate cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
23 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2002
CompletedFirst Posted
Study publicly available on registry
December 4, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2004
CompletedJune 7, 2012
June 1, 2012
December 3, 2002
June 6, 2012
Conditions
Interventions
Sponsors & Collaborators
- Astellas Pharma Inclead
- Astellas Pharma US, Inc.collaborator
Study Sites (23)
University Clinic AZ
Brussels, Belgium
University Clinic UCL St. Luc
Brussels, Belgium
Private Urology Out-patient Ward
Jablonec nad Nisou, Czechia
Clinic of Urology, University Hospital
Králové, Czechia
Clinic of Urology, University Hospital
Olomouc, Czechia
Clinic of Urology, University Hospital
Prague, Czechia
Hôpital Bichat, service de Urology
Paris, France
Haingasse 22
Bad Homburg, 61348, Germany
Klinik und Poliklinik für Urologie, Universitätsklinikum Carl-Gustav-Carus
Dresden, Germany
Klinik u. Poliklinik für Urologie, Philipps Universität, Baldingerstraße
Marburg, Germany
Krummbogen 15
Marburg, Germany
Regional Hospital, Department of Urology
Bydgoszcz, Poland
MedSource Poland
Gdansk, Poland
Bielanski Hospital, Department of Urology
Warsaw, Poland
Oncology Center, Department of Urinary Tract Cancer
Warsaw, Poland
Medical University, Clinic of Urology
Wroclaw, Poland
Complejo Hospitaliaro Juan Canalejo, Servicio de Urología
Corunna, Spain
Fundacion Hospital Alcorcón, Servicio Urología
Madrid, Spain
Hospital Universitario Principe de Asturias, Servicio de Urología, Ctra.
Madrid, Spain
Department of Urology, Bristol Royal Infirmary
Bristol, United Kingdom
Department of Urology, Gartnavel Hospital
Glasgow, United Kingdom
Department of Urology, Norfolk & Norwich Hospital
Norwich, United Kingdom
Department of Urology, Taunton & Somerset Hospital
Taunton, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
December 3, 2002
First Posted
December 4, 2002
Study Completion
February 1, 2004
Last Updated
June 7, 2012
Record last verified: 2012-06